ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $248 | -99.9% | 4,280 | -20.9% | 0.02% | -10.7% |
| Q4 2021 | $250,000 | +3.3% | 5,410 | +30.2% | 0.03% | -22.2% |
| Q1 2018 | $242,000 | -49.5% | 4,155 | -44.2% | 0.04% | -57.6% |
| Q4 2017 | $479,000 | +128.1% | 7,442 | +65.9% | 0.08% | +112.5% |
| Q2 2017 | $210,000 | – | 4,485 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |